z-logo
open-access-imgOpen Access
A Novel Cinnamide YLT26 Induces Breast Cancer Cells ApoptosisviaROS-Mitochondrial Apoptotic Pathwayin Vitroand Inhibits Lung Metastasisin Vivo
Author(s) -
Ying Xiong,
Tinghong Ye,
Mengyao Wang,
Yong Xia,
Ningyu Wang,
Xuejiao Song,
Fengtian Wang,
Li Liu,
Yongxia Zhu,
Fangfang Yang,
Yuquan Wei,
Luoting Yu
Publication year - 2014
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000366385
Subject(s) - apoptosis , cancer research , metastasis , breast cancer , in vivo , lung cancer , biology , cancer , medicine , chemistry , pathology , biochemistry , microbiology and biotechnology
Breast cancer is the leading cause of cancer death among women worldwide and metastasis is the major cause of treatment failure. Thus, new treatment options for breast cancer, especially, drugs which could prevent metastasis, are pressingly needed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom